Review





Similar Products

receiver operator characteristics curve auroc analysis  (Genovis Inc)
93
Genovis Inc receiver operator characteristics curve auroc analysis
Receiver Operator Characteristics Curve Auroc Analysis, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pm40593901-123-2-2?v=Genovis+Inc
Average 93 stars, based on 1 article reviews
receiver operator characteristics curve auroc analysis - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
liver fibrosis regression auroc analysis  (Omics Data Automation)
86
Omics Data Automation liver fibrosis regression auroc analysis
Liver Fibrosis Regression Auroc Analysis, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pm41922110-263-6-15?v=Omics+Data+Automation
Average 86 stars, based on 1 article reviews
liver fibrosis regression auroc analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
auroc analysis  (MedCalc Software Ltd)
90
MedCalc Software Ltd auroc analysis
<t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
Auroc Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pmc11795793-91-2-20?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
auroc analysis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
analysis of the (auroc)  (MedCalc Software Ltd)
90
MedCalc Software Ltd analysis of the (auroc)
<t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
Analysis Of The (Auroc), supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pm37023561-84-7-11?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
analysis of the (auroc) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14  (STATA Corporation)
99
STATA Corporation auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14
<t> Prognostic </t> performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).
Auroc Values 0 60 Were Considered Poorly Predictive 21 Statistical Analysis Was Performed Using Stata 14, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pm35419955-49-0-12?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
auroc values 0 60 were considered poorly predictive 21 statistical analysis was performed using stata 14 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
receiver operating characteristic analysis auroc  (MedCalc Software Ltd)
90
MedCalc Software Ltd receiver operating characteristic analysis auroc
ROC analysis of the potential of ANRIL <t>and</t> <t>HOXA11-AS</t> to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL <t>(auROC=0.755;</t> 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.
Receiver Operating Characteristic Analysis Auroc, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/pmc08713178-97-20-23?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
receiver operating characteristic analysis auroc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
auroc curve analysis  (MedCalc Software Ltd)
90
MedCalc Software Ltd auroc curve analysis
ROC analysis of the potential of ANRIL <t>and</t> <t>HOXA11-AS</t> to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL <t>(auROC=0.755;</t> 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.
Auroc Curve Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auroc+analysis/10__3171_slash_2018__1__jns171906-58-4-10?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
auroc curve analysis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).

Journal: Heliyon

Article Title: Role of C5aR2 in prognosis of patients with acute respiratory distress syndrome through negative modulation of C5a: A prospective observational study

doi: 10.1016/j.heliyon.2025.e42146

Figure Lengend Snippet: Prognostic performance of C5a, C5aR2 and C5a/C5aR2 ratio for non-recovery in ARDS patients (N = 64).

Article Snippet: Area under receiver operating characteristic (AUROC) was used to analyse the prognostic performance of C5a, C5R2, and C5a/C5R2 ratio using MedCalc.

Techniques:

ROC analysis of the potential of ANRIL and HOXA11-AS to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL (auROC=0.755; 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.

Journal: Experimental and Therapeutic Medicine

Article Title: Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis

doi: 10.3892/etm.2021.11038

Figure Lengend Snippet: ROC analysis of the potential of ANRIL and HOXA11-AS to predict ISR. ROC analysis was used to test the values of ANRIL and HOXA11-AS for the prediction of ISR. High ANRIL (auROC=0.755; 95% CI=0.702-0.803) expression (green line) and low HOXA11-AS (auROC=0.712; 95% CI=0.657-0.763) expression (yellow line) predicted high risk for ISR (P<0.05). Combined scores of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) expression (blue line) had a better performance for the prediction of ISR than ANRIL or HOXA11-AS alone (P<0.05). auROC, area under the curve of a receiver operating characteristic analysis; ISR, in-stent restenosis; Lnc, long non-coding RNA; ANRIL, antisense non-coding RNA at the INK4 locus; HOXA11-AS, homeobox A11-antisense.

Article Snippet: To assess differences in prognostic efficiency involving ANRIL and HOXA11-AS, the area under the curve of a receiver operating characteristic analysis (auROC) using MedCalc, which is a measure of discrimination, was calculated.

Techniques: Expressing